It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Optical microscopy is an indispensable tool in biomedical sciences, but its reach in deep tissues is limited due to aberrations and scattering. This problem can be overcome by wavefront-shaping techniques, albeit at limited fields of view (FOVs). Inspired by astronomical imaging, conjugate wavefront shaping can lead to an increased field of view in microscopy, but this correction is limited to a set depth and cannot be dynamically adapted. Here, we present a conjugate wavefront-shaping scheme based on focus scanning holographic aberration probing (F-SHARP). We combine it with a compact implementation that can be readily adapted to a variety of commercial and home-built two-photon microscopes. We demonstrate the power of the method by imaging with high resolution over extended FOV (>80 µm) deeper than 400 μm inside a mouse brain through a thinned skull.
Microscopy: sharp, deep, wide images with F-SHARP
A new microscopic approach helps obtain sharp images, with a wide field of view, in deep tissues. Focus scanning holographic aberration probing (F-SHARP) was developed by Benjamin Judkewitz of Charité–Universitätsmedizin Berlin and colleagues in Germany. This microscopic scheme can be readily adapted to a variety of two-photon microscopes. The team used their method for imaging neurons in live mice brains through a thinned skull, providing images with a field of view of wider than 80 µm and to a depth of more than 400 µm. F-SHARP uses wavefront shaping and a spatial light modulator to correct the aberrations and scattering that occur when light from a microscope interacts with an inhomogeneous scattering layer, such as a skull when viewing underlying brain tissue. The corrections undo the scattering to focus the image of the underlying tissue.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Charité – Universitätsmedizin Berlin, Einstein Center for Neurosciences, NeuroCure Cluster of Excellence, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662)
2 Max Delbrück Center for Molecular Medicine, Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849)
3 Humboldt University, Institute for Biology, Berlin, Germany (GRID:grid.7468.d) (ISNI:0000 0001 2248 7639)




